Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Shanghai Jiao Tong University School of Medicine
Aegera Therapeutics